Literature DB >> 1513754

In situ hybridization studies for the detection of common aneuploidies in CVS.

L Zahed1, M Murer-Orlando, M Vekemans.   

Abstract

We have attempted to evaluate the efficiency of interphase cytogenetics in the detection of specific aneuploidies in chorionic villus samples. For this purpose, we used alphoid repetitive sequences specific for the chromosomes involved in the common aneuploidies, namely probes for chromosomes 13, 18, 21, X, and Y. These probes were applied to normal and abnormal CVS cases, as well as to a few mosaic cases. Results from these preliminary studies indicate that the technique can be very efficient for the detection of specific aneuploidies and can be particularly useful in the analysis of mosaic cases, which usually requires the screening of a high number of metaphases.

Mesh:

Year:  1992        PMID: 1513754     DOI: 10.1002/pd.1970120603

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  4 in total

Review 1.  Demystified ... FISH.

Authors:  J J Waters; A L Barlow; C P Gould
Journal:  Mol Pathol       Date:  1998-04

2.  Rapid prenatal diagnosis of chromosomal aneuploidies by fluorescence in situ hybridization: clinical experience with 4,500 specimens.

Authors:  B E Ward; S L Gersen; M P Carelli; N M McGuire; W R Dackowski; M Weinstein; C Sandlin; R Warren; K W Klinger
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

3.  Use of the primed in situ labelling (PRINS) technique for a rapid detection of chromosomes 13, 16, 18, 21, X and Y.

Authors:  F Pellestor; A Girardet; G Lefort; B Andréo; J P Charlieu
Journal:  Hum Genet       Date:  1995-01       Impact factor: 4.132

4.  Prenatal diagnosis from maternal blood: simultaneous immunophenotyping and FISH of fetal nucleated erythrocytes isolated by negative magnetic cell sorting.

Authors:  Y L Zheng; N P Carter; C M Price; S M Colman; P J Milton; G A Hackett; M F Greaves; M A Ferguson-Smith
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.